According to the report published by Allied Market Research, the global Next Generation Sequencing (NGS) Market was pegged at $6.59 billion in 2020 and is estimated to hit $35.50 billion by 2030, registering a CAGR of 18.2% from 2021 to 2030. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and changing market trends.
Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/2048
High-end technological advancements in NGS, surge in applications of NGS, and rise in demand for genome mapping programs drive the growth of the global next generation sequencing (NGS) market. On the other hand, standardization concerns over NGS-based diagnostics, lack of skilled professionals, and several ethical and legal limitations restrain the growth to some extent. However, increase in demand for cloud computing and potential data management services are anticipated to pave the way for lucrative opportunities in the industry.
COVID-19 scenario-
• The NGS diagnostic technology comes with immense potential to determine the genetic sequence of a virus, thereby helping scientists recognize the mutation of the virus. This factor has impacted the NGS market positively.
• At the same time, genome sequencing has also been used to understand the spread of COVID-19, thus improving the treatments.
The global next generation sequencing (NGS) market is analyzed across product, application, technology, end user, and region. Based on product type, the consumables segment accounted for more than two-thirds of the total market revenue in 2020, and is projected to rule the roost by the end of 2030. The services segment, on the other hand, would cite the fastest CAGR of 19.3% throughout the forecast period.
Enquiry for Short-term and Long-term Impacts of COVID-19 at: https://www.alliedmarketresearch.com/purchase-enquiry/2048
Based on application, the biomarkers & cancer segment contributed to more than one-third of the total market share in 2020, and is expected to lead the trail by 2030. The agriculture and animal research segment, however, would also grow at the fastest CAGR of 19.2% from 2021 to 2030.
Based on geography, North America held the major share in 2020, garnering around two-fifths of the global market. Simultaneously, the market across Asia-Pacific would exhibit the fastest CAGR of 19.0% by 2030. The other two provinces discussed in the report include Europe and LAMEA.
The leading market players analyzed in the global NGS market report include BGI Group, F. Hoffmann-La Roche AG, Precigen Inc., (Intrexon Bioinformatics Germany GmbH), Pacific Biosciences of California, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, PerkinElmer, Inc., Illumina Inc, PierianDx Inc., and Qiagen N.V. These market players have incorporated different strategies including partnership, expansion, collaboration, joint ventures, and others to brace their stand in the industry.
We also Offers Regional and Country Reports-
• Japan Radiotherapy Market
• South Korea Radiotherapy Market
• Singapore Radiotherapy Market
• China Radiotherapy Market
• Indonesia Radiotherapy Market
• Australia Radiotherapy Market
• Taiwan Radiotherapy Market
Trending Reports in Healthcare Industry:
Healthcare CRM Market Analysis & Industry Forecast, 2021 – 2030
Scaffold Technology Market Analysis & Industry Forecast, 2020-2027
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter
Benefits of Purchasing Next Generation Sequencing (NGS) Market Reports:
• Customer Satisfaction: Our team of experts assists you with all your research needs and optimizes your reports.
• Analyst Support: Before or after purchasing the report, ask a professional analyst to address your questions.
• Assured Quality: Focuses on accuracy and quality of reports.
• Incomparable Skills: Analysts provide in-depth insights into reports.
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact Us:
David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022,
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975